(Q37817023)

23 August 2017

1 reference

title

The plasmin-antiplasmin system: structural and functional aspects (English)

1 reference

23 August 2017

Johann Schaller

1

1 reference

23 August 2017

Simon S Gerber

series ordinal

2

1 reference

23 August 2017

publication date

7 December 2010

1 reference

Cellular and Molecular Life Sciences

23 August 2017

published in

1 reference

23 August 2017

volume

68

1 reference

23 August 2017

issue

5

1 reference

23 August 2017

page(s)

785-801

1 reference

https://scigraph.springernature.com/pub.10.1007/s00018-010-0566-5

23 August 2017

exact match

0 references

cites work

Novel aspects and new roles for the serine protease plasmin.

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

Regulation and interactions in the activation of cell-associated plasminogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

Synthesis of human plasminogen by the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

Molecular cloning and characterization of a full-length cDNA clone for human plasminogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

Plasminogen is tethered with high affinity to the cell surface by the plasma protein, histidine-rich glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

The PAN module: the N-terminal domains of plasminogen and hepatocyte growth factor are homologous with the apple domains of the prekallikrein family and with a novel domain found in numerous nematode proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

Crystal structure of the catalytic domain of human plasmin complexed with streptokinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

Serine-578 is a major phosphorylation locus in human plasma plasminogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

Human plasminogen catalytic domain undergoes an unusual conformational change upon activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

Direct evidence for the generation of an active site in the plasminogen moiety of the streptokinase-human plasminogen activator complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

Crystal structures of the recombinant kringle 1 domain of human plasminogen in complexes with the ligands epsilon-aminocaproic acid and trans-4-(aminomethyl)cyclohexane-1-carboxylic Acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

Secondary-site binding of Glu-plasmin, Lys-plasmin and miniplasmin to fibrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

On the specific interaction between the lysine-binding sites in plasmin and complementary sites in α2-antiplasmin and in fibrinogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

Structural/functional characterization of the alpha 2-plasmin inhibitor C-terminal peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

Identification of amino acids in antiplasmin involved in its noncovalent 'lysine-binding-site'-dependent interaction with plasmin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

Kringle 2 mediates high affinity binding of plasminogen to an internal sequence in streptococcal surface protein PAM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

Expression, purification and characterization of the recombinant kringle 2 and kringle 3 domains of human plasminogen and analysis of their binding affinity for omega-aminocarboxylic acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

Structure and ligand binding determinants of the recombinant kringle 5 domain of human plasminogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

The human alpha(2)-plasmin inhibitor: functional characterization of the unique plasmin(ogen)-binding region

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

Interactions of plasminogen with polymerizing fibrin and its derivatives, monitored with a photoaffinity cross-linker and electron microscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

The X-ray crystallographic structure of the angiogenesis inhibitor angiostatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

The molecular weights, mass distribution, chain composition, and structure of soluble fibrin degradation products released from a fibrin clot perfused with plasmin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

Androgen-dependent fibrinolytic activity in a murine mammary carcinoma (shionogi SC-115 cells) in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

Increased capillary endothelial cell protease activity in response to angiogenic stimuli in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

Collagen dissolution by keratinocytes requires cell surface plasminogen activation and matrix metalloproteinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

Mechanism of factor Va inactivation by plasmin. Loss of A2 and A3 domains from a Ca2+-dependent complex of fragments bound to phospholipid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

Effects of plasmin on von Willebrand factor multimers. Degradation in vitro and stimulation of release in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

Genetic susceptibility to venous thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

Two types of abnormal genes for plasminogen in families with a predisposition for thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

21 January 2018

Ligneous conjunctivitis

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

Latent tissue plasminogen activator produced by human endothelial cells in culture: evidence for an enzyme-inhibitor complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

Extracellular proteolysis in the adult murine brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

Tissue plasminogen activator has an O-linked fucose attached to threonine-61 in the epidermal growth factor domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

Cloning and expression of human tissue-type plasminogen activator cDNA in E. coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

The structure of the human tissue-type plasminogen activator gene: correlation of intron and exon structures to functional and structural domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

Structural and kinetic comparison of recombinant human single- and two-chain tissue plasminogen activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

Solution structure of the tissue-type plasminogen activator kringle 2 domain complexed to 6-aminohexanoic acid an antifibrinolytic drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

Crystal structure of the kringle 2 domain of tissue plasminogen activator at 2.4-.ANG. resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

The solution structure and backbone dynamics of the fibronectin type I and epidermal growth factor-like pair of modules of tissue-type plasminogen activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

The 2.3 A crystal structure of the catalytic domain of recombinant two-chain human tissue-type plasminogen activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

Lysine 156 promotes the anomalous proenzyme activity of tPA: X-ray crystal structure of single-chain human tPA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

Plasminogen activator activity in cultures from human tissues. An immunological and histochemical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

Purification of zymogen to plasminogen activator from human glioblastoma cells by affinity chromatography with monoclonal antibody.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

Characterization of a posttranslational fucosylation in the growth factor domain of urinary plasminogen activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

Phosphorylation of human pro-urokinase on Ser138/303 impairs its receptor-dependent ability to promote myelomonocytic adherence and motility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

The human urokinase-plasminogen activator gene and its promoter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

Solution structure of the amino-terminal fragment of urokinase-type plasminogen activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

Heparin binding to the urokinase kringle domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

Solution structure of the kringle domain from urokinase-type plasminogen activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

Chemical modification of the urokinase-type plasminogen activator and its receptor using tetranitromethane. Evidence for the involvement of specific tyrosine residues in both molecules during receptor-ligand interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

Engineering inhibitors highly selective for the S1 sites of Ser190 trypsin-like serine protease drug targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

The urokinase-type plasminogen activator system in cancer metastasis: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

Conformational properties of serine proteinase inhibitors (serpins) confer multiple pathophysiological roles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel functions, and a revised nomenclature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

An overview of the serpin superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

Exosite determinants of serpin specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

Phylogeny of the serpin superfamily: implications of patterns of amino acid conservation for structure and function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

Serpins: structure, function and molecular evolution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

Keeping the serpin machine running smoothly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

Antiplasmin: the forgotten serpin?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

Congenital alpha(2)-plasmin inhibitor deficiencies: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

Synthesis and secretion of alpha 2-plasmin inhibitor by established human liver cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

Differences between neonates and adults in carbohydrate sequences and reaction kinetics of plasmin and alpha(2)-antiplasmin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

Assignment of a single disulphide bridge in human alpha2-antiplasmin: implications for the structural and functional properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

Organization of the human alpha 2-plasmin inhibitor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

Different NH2-terminal form with 12 additional residues of alpha 2-plasmin inhibitor from human plasma and culture media of Hep G2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

A novel plasma proteinase potentiates alpha2-antiplasmin inhibition of fibrin digestion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

X-ray crystal structure of the fibrinolysis inhibitor alpha2-antiplasmin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

Significance of cross-linking of alpha 2-plasmin inhibitor to fibrin in inhibition of fibrinolysis and in hemostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

Kinetic properties of the primary inhibitor of plasmin from human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

On the Kinetics of the Reaction between Human Antiplasmin and Plasmin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

On the Kinetics of the Reaction between Human Antiplasmin and a Low-Molecular-Weight Form of Plasmin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

Molecular basis for congenital deficiency of alpha 2-plasmin inhibitor. A frameshift mutation leading to elongation of the deduced amino acid sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

Structure of the human alpha-2 macroglobulin gene and its promotor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

Characterization of the reaction of plasmin with alpha 2-macroglobulin: effect of antifibrinolytic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

Alpha-2 macroglobulin is genetically associated with Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

Structure of the human plasminogen activator inhibitor 1 gene: nonrandom distribution of introns

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

Plasminogen activator inhibitor type-1: reactive center and amino-terminal heterogeneity determined by protein and cDNA sequencing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

Interfering with the inhibitory mechanism of serpins: crystal structure of a complex formed between cleaved plasminogen activator inhibitor type 1 and a reactive-centre loop peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

Purification of active human plasminogen activator inhibitor 1 from Escherichia coli. Comparison with natural and recombinant forms purified from eucaryotic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

Bovine plasminogen activator inhibitor 1: specificity determinations and comparison of the active, latent, and guanidine-activated forms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

Detection and partial characterization of an inhibitor of plasminogen activator in human platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

The undecided serpin. The ins and outs of plasminogen activator inhibitor type 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

Plasminogen activator inhibitor 2: regulation of gene transcription during phorbol ester-mediated differentiation of U-937 human histiocytic lymphoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

Human monocyte Arg-Serpin cDNA. Sequence, chromosomal assignment, and homology to plasminogen activator-inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

Plasminogen activator-specific inhibitors produced by human monocytes/macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

The plasminogen activator inhibitor-2 gene is not required for normal murine development or survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

Phorbol ester induces the biosynthesis of glycosylated and nonglycosylated plasminogen activator inhibitor 2 in high excess over urokinase-type plasminogen activator in human U-937 lymphoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

Chromosomal organization and localization of the human urokinase inhibitor gene: perfect structural conservation with ovalbumin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

The crystal structure of plasminogen activator inhibitor 2 at 2.0 A resolution: implications for serpin function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

Plasminogen-activator inhibitor type 2 (PAI-2) is a spontaneously polymerising SERPIN. Biochemical characterisation of the recombinant intracellular and extracellular forms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

Neuroserpin: a serpin to think about

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

Neuroserpin, a brain-associated inhibitor of tissue plasminogen activator is localized primarily in neurons. Implications for the regulation of motor learning and neuronal survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

Human neuroserpin (PI12): cDNA cloning and chromosomal localization to 3q26

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

Biochemical characterization of a neuroserpin variant associated with hereditary dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

Human neuroserpin: structure and time-dependent inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

The axonally secreted serine proteinase inhibitor, neuroserpin, inhibits plasminogen activators and plasmin but not thrombin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

Evidence that a variety of cultured cells secrete protease nexin and produce a distinct cytoplasmic serine protease-binding factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

The gene for the serpin thrombin inhibitor (PI7), protease nexin I, is located on human chromosome 2q33-q35 and on syntenic regions in the mouse and sheep genomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

The SERPINE2 gene is associated with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0566-5

Antibodies to plasminogen activator inhibit human tumor metastasis

21 January 2018

1 reference

12 December 2020

The N-and O-linked carbohydrate chains of human, bovine and porcine plasminogen. Species specificity in relation to sialylation and fucosylation patterns

1 reference

12 December 2020

High resolution analysis of functional determinants on human tissue-type plasminogen activator

1 reference

12 December 2020

Proton magnetic resonance study of lysine-binding to the kringle 4 domain of human plasminogen. The structure of the binding site

1 reference

12 December 2020

Neuroserpin, an axonally secreted serine protease inhibitor

1 reference

12 December 2020

Isolation and characterization of the human tissue-type plasminogen activator structural gene including its 5' flanking region

1 reference

12 December 2020

A unique interhelical insertion in plasminogen activator inhibitor-2 contains three glutamines, Gln83, Gln84, Gln86, essential for transglutaminase-mediated cross-linking

1 reference

12 December 2020

Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction

1 reference

12 December 2020

Carbohydrate of the human plasminogen variants. III. Structure of the O-glycosidically linked oligosaccharide unit

1 reference

12 December 2020

Endothelial plasminogen activator inhibitor (PAI): a new member of the Serpin gene family

1 reference

12 December 2020

Identification of the plasminogen-binding site of human alpha 2-plasmin inhibitor

1 reference

12 December 2020

A novel missense mutation in the human plasmin inhibitor (alpha2-antiplasmin) gene associated with a bleeding tendency

1 reference

12 December 2020

Structure of the gene for human plasminogen activator inhibitor-2. The nearest mammalian homologue of chicken ovalbumin

1 reference

12 December 2020

Basic and clinical aspects of fibrinolysis and thrombolysis

1 reference

12 December 2020

Linkage disequilibrium of plasminogen polymorphisms and assignment of the gene to human chromosome 6q26-6q27.

1 reference

12 December 2020

Recombinant gene expression and 1H NMR characteristics of the kringle (2 + 3) supermodule: spectroscopic/functional individuality of plasminogen kringle domains

1 reference

12 December 2020

Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin

1 reference

12 December 2020

Laminin degradation by plasmin regulates long-term potentiation

1 reference

12 December 2020

Alpha 2-macroglobulin, a multifunctional binding protein with targeting characteristics

1 reference

12 December 2020

Purification and characterization of a plasminogen activator inhibitor from the histiocytic lymphoma cell line U-937

1 reference

12 December 2020

The efficiency of the uncleaved secretion signal in the plasminogen activator inhibitor type 2 protein can be enhanced by point mutations that increase its hydrophobicity

1 reference

12 December 2020

Carbohydrate of the human plasminogen variants. I. Carbohydrate composition, glycopeptide isolation, and characterization

1 reference

12 December 2020

A 55,000-60,000 Mr receptor protein for urokinase-type plasminogen activator. Identification in human tumor cell lines and partial purification

1 reference

12 December 2020

Cathepsin B efficiently activates the soluble and the tumor cell receptor-bound form of the proenzyme urokinase-type plasminogen activator (Pro-uPA)

1 reference

12 December 2020

A proenzyme form of human urokinase

1 reference

12 December 2020

Evidence for a novel O-linked sialylated trisaccharide on Ser-248 of human plasminogen 2

1 reference

12 December 2020

Protease nexin. Properties and a modified purification procedure

1 reference

12 December 2020

Cross-linking site in fibrinogen for alpha 2-plasmin inhibitor

1 reference

12 December 2020

Mechanism of the urokinase-catalyzed activation of human plasminogen

1 reference

12 December 2020

Properties of three different molecular forms of the alpha 2 plasmin inhibitor

1 reference

12 December 2020

The receptor-binding sequence of urokinase. A biological function for the growth-factor module of proteases

1 reference

12 December 2020

Isolation and characterization of a human plasma protein with affinity for the lysine binding sites in plasminogen. Role in the regulation of fibrinolysis and identification as histidine-rich glycoprotein

1 reference

12 December 2020

Facultative polypeptide translocation allows a single mRNA to encode the secreted and cytosolic forms of plasminogen activators inhibitor 2

1 reference

12 December 2020

Cross-linking of plasminogen activator inhibitor 2 and alpha 2-antiplasmin to fibrin(ogen)

1 reference

12 December 2020

The activation by staphylokinase of human plasminogen

1 reference

12 December 2020

Carbohydrate of the human plasminogen variants. II. Structure of the asparagine-linked oligosaccharide unit

1 reference

12 December 2020

Plasminogen: a structural review

1 reference

12 December 2020

The peptide chains of human plasmin. Mechanism of activation of human plasminogen to plasmin

1 reference

12 December 2020

Familial dementia caused by polymerization of mutant neuroserpin

1 reference

12 December 2020

Identification of a PAI-1 binding site in vitronectin

1 reference

12 December 2020

Plasminogen activation in healing human wounds

1 reference

12 December 2020

Isolation of a new specific plasminogen activator inhibitor from pregnancy plasma

1 reference

12 December 2020

Expression, isolation and characterization of a mutated human plasminogen kringle 3 with a functional lysine binding site

1 reference

12 December 2020

Plasminogen activators and cancer

1 reference

12 December 2020

Structure and function of the plasminogen/plasmin system

1 reference

12 December 2020

Neuroserpin: a selective inhibitor of tissue-type plasminogen activator in the central nervous system

1 reference

12 December 2020

Alpha-macroglobulins: structure, shape, and mechanism of proteinase complex formation

1 reference

12 December 2020

Plasma levels of a specific inhibitor of tissue-type plasminogen activator (and urokinase) in normal and pathological conditions

1 reference

12 December 2020

Ligand preferences of kringle 2 and homologous domains of human plasminogen: canvassing weak, intermediate, and high-affinity binding sites by 1H-NMR

1 reference

12 December 2020

Functional sites of glia-derived nexin (GDN): importance of the site reacting with the protease

1 reference

12 December 2020

An endothelial cell receptor for plasminogen/tissue plasminogen activator (t-PA). II. Annexin II-mediated enhancement of t-PA-dependent plasminogen activation

1 reference

12 December 2020

Human plasminogen activator inhibitor-1 (PAI-1) deficiency: characterization of a large kindred with a null mutation in the PAI-1 gene

1 reference

12 December 2020

An endothelial cell receptor for plasminogen/tissue plasminogen activator. I. Identity with annexin II.

1 reference

12 December 2020

Sulfation of a tyrosine residue in the plasmin-binding domain of alpha 2-antiplasmin

1 reference

12 December 2020

The complete amino acid sequence of low molecular mass urokinase from human urine

1 reference

12 December 2020

The mutual relationship between the two molecular forms of the major fibrinolysis inhibitor alpha-2-antiplasmin in blood

1 reference

12 December 2020

Plasminogen activator in early embryogenesis: enzyme production by trophoblast and parietal endoderm

1 reference

12 December 2020

Primary structure of human alpha 2-macroglobulin. Complete disulfide bridge assignment and localization of two interchain bridges in the dimeric proteinase binding unit.

1 reference

12 December 2020

Biological and clinical aspects of plasminogen activator inhibitor type 2.

1 reference

12 December 2020

Purification and characterization of natural and recombinant human plasminogen activator inhibitor-1 (PAI-1)

1 reference

12 December 2020

Primary structure of human alpha 2-macroglobulin. V. The complete structure

1 reference

12 December 2020

Alpha-2-antiplasmin: a serpin with two separate but overlapping reactive sites

1 reference

12 December 2020

Alteration of serpin specificity by a protein cofactor. Vitronectin endows plasminogen activator inhibitor 1 with thrombin inhibitory properties

1 reference

12 December 2020

Production of Plasminogen Activator Inhibitor 1 by Human Adipose Tissue: Possible Link Between Visceral Fat Accumulation and Vascular Disease

1 reference

12 December 2020

Solution structure and dynamics of the plasminogen kringle 2-AMCHA complex: 3(1)-helix in homologous domains

1 reference

12 December 2020

cDNA cloning and expression in Escherichia coli of a plasminogen activator inhibitor from human placenta

1 reference

12 December 2020

The interaction between plasminogen and antiplasmin variants as studied by surface plasmon resonance

1 reference

12 December 2020

The cell-binding domains of plasminogen and their function in plasma

1 reference

12 December 2020

Carbohydrate structure of recombinant human uterine tissue plasminogen activator expressed in mouse epithelial cells

1 reference

12 December 2020

Proteolysis of subendothelial adhesive glycoproteins (fibronectin, thrombospondin, and von Willebrand factor) by plasmin, leukocyte cathepsin G, and elastase

1 reference

12 December 2020

Plasminogen activators, tissue degradation, and cancer

1 reference

12 December 2020

On the target specificity of plasminogen activator inhibitor 1: the role of heparin, vitronectin, and the reactive site

1 reference

12 December 2020

Primary structure of the 'bait' region for proteinases in alpha 2-macroglobulin. Nature of the complex

1 reference

12 December 2020

Characterization of the gene for human plasminogen, a key proenzyme in the fibrinolytic system

1 reference

12 December 2020

PAM, a novel plasminogen-binding protein from Streptococcus pyogenes.

1 reference

12 December 2020

Identification of the domains of tissue-type plasminogen activator involved in the augmented binding to fibrin after limited digestion with plasmin

1 reference

12 December 2020

On the mechanism of the reaction between human alpha 2-antiplasmin and plasmin

1 reference

12 December 2020

Expression and characterization of pro alpha 2-plasmin inhibitor

1 reference

12 December 2020

Primary structure of human alpha 2-antiplasmin, a serine protease inhibitor (serpin)

1 reference

12 December 2020

10.1007/S00018-010-0566-5

Identifiers

DOI

1 reference

23 August 2017

1 reference